← BioLineRx Ltd.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income | — | — | — | — | — | — | ($25.0m) |
($60.6m)
-142.93%
|
($9.2m)
+84.79%
|
($1.2m)
+87.26%
|
($9.7m)
-729.02%
|
|
| Profit or Loss | ($15.8m) | ($24.4m) | ($23.0m) | ($25.4m) | ($30.0m) | ($27.1m) | ($25.0m) | ($60.6m) | ($9.2m) | ($2.0m) | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $654k | $1.4m | $4.1m | $523k | $446k | |
| Depreciation And Amortization | — | — | — | — | — | — | $654k | $1.4m | $4.1m | $523k | $446k | |
| Adjustments For Share-Based Payments | $1.1m | $1.5m | $2.5m | $1.8m | $1.3m | $1.5m | $2.2m | $2.3m | $1.1m | $396k | — | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | $6.7m | $1.3m | $0 | $0 | |
| Change In Working Capital | — | — | — | — | — | — | $1.2m | $15.2m | ($21.8m) | $1.3m | $2.3m | |
| Change In Receivables | — | — | — | — | — | — | $0 | ($358k) | ($2.1m) | $2.4m | $1.5m | |
| Changes In Account Receivables | — | — | — | — | — | — | $0 | ($358k) | ($2.1m) | $2.4m | $1.5m | |
| Change In Inventory | — | — | — | — | — | — | $0 | ($2.0m) | ($1.2m) | $997k | $1.2m | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $1.9m | $5.5m | ($5.5m) | ($3.5m) | $966k | |
| Capital Expenditure | — | — | — | — | — | — | ($316k) | ($297k) | ($54k) | ($27k) | ($27k) | |
| Proceeds From Borrowings Classified As Financing Activities | — | — | — | — | — | — | $18.2m | — | $27.9m | $9.1m | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | $318k | $889k | $3.1m | $3.4m | $2.8m | $1.5m | $22.8m | $5.6m | — | |
| Issuance Of Debt | — | — | — | — | — | — | $9.1m | $0 | $19.2m | $0 | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | — | $9.1m | $0 | $19.2m | $0 | $0 | |
| Long Term Debt Payments | — | — | — | — | — | — | ($3.1m) | ($445k) | ($511k) | ($512k) | ($445k) | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $6.1m | ($2.0m) | $4.3m | ($5.0m) | ($4.9m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $6.1m | ($445k) | $18.7m | ($512k) | ($445k) | |
| Net Short Term Debt Issuance | — | — | — | — | — | — | — | ($1.5m) | ($14.4m) | ($4.5m) | ($4.5m) | |
| Repayment Of Debt | — | — | — | — | — | — | ($3.1m) | ($2.0m) | ($14.9m) | ($5.0m) | ($445k) | |
| Short Term Debt Payments | — | — | — | — | — | — | — | ($1.5m) | ($14.4m) | ($4.5m) | ($4.5m) | |
| Common Stock Issuance | — | — | — | — | — | — | $14.4m | $14.1m | $16.4m | $13.9m | $3.2m | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $14.4m | $14.1m | $16.4m | $13.9m | $3.2m | |
| Beginning Cash Position | — | — | — | — | — | — | $13.0m | $10.6m | $4.3m | $10.4m | $9.0m | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | ($607k) | ($224k) | $22k | $549k | $642k | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Additional Financial Items | ||||||||||||
| Adjustments For Increase Decrease In Trade Account Payable | $369k | $3.1m | ($773k) | $3.2m | ($1.7m) | ($564k) | $1.9m | $5.5m | ($5.5m) | ($3.5m) | — | |
| Adjustments For Unrealised Foreign Exchange Losses Gains | ($51k) | ($435k) | $166k | ($108k) | ($206k) | ($207k) | $607k | $224k | ($22k) | ($549k) | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | $215k | $224k | $196k | $220k | $445k | $511k | $512k | — | |
| Proceeds From Issuing Shares | $2.2m | $38.8m | $3.8m | $20.3m | $21.2m | $50.4m | $14.4m | $14.1m | $16.4m | $13.9m | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | $3k | $3.9m | $10.0m | $6k | — | $0 | $185k | $181k | $1k | $2k | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $20.4m | $15.1m | $20.7m | $8.9m | ($1.7m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | $4.0m | $1.4m | $29.4m | ($8.5m) | $2.3m | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($1.8m) | ($6.1m) | $6.2m | ($7.7m) | — | |
| Change In Other Working Capital | — | — | — | — | — | — | — | $13.0m | ($13.0m) | — | ($13.0m) | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($650k) | ($959k) | ($43k) | $1.3m | ($1.3m) | |
| Changes In Cash | — | — | — | — | — | — | ($1.8m) | ($6.1m) | $6.2m | ($7.7m) | ($7.2m) | |
| End Cash Position | — | — | — | — | — | — | $10.6m | $4.3m | $10.4m | $3.2m | $1.9m | |
| Financing Cash Flow | — | — | — | — | — | — | $20.4m |
$15.1m
-26.33%
|
$20.7m
+37.21%
|
$8.9m
-56.99%
|
($1.7m)
-119.65%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($26.6m) | ($22.9m) | ($43.9m) | ($8.1m) | ($7.8m) | |
| Gain Loss On Investment Securities | — | — | — | — | — | — | ($6.3m) | $11.1m | ($18.3m) | ($7.9m) | ($724k) | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | — | — | $0 | $0 | $25k | $25k | |
| Interest Paid Supplemental Data | — | — | — | — | — | — | $593k | $1.1m | $10.4m | $1.3m | $1.2m | |
| Investing Cash Flow | — | — | — | — | — | — | $4.0m | $1.4m | $29.4m | ($8.5m) | $2.3m | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | $383k | $182k | ($53k) | ($372k) | ($450k) | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | — | ($185k) | ($181k) | ($1k) | ($2k) | ($2k) | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | $4.3m | $1.7m | $29.4m | ($8.5m) | $2.4m | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($131k) | ($116k) | ($53k) | ($25k) | ($31k) | |
| Operating Gains Losses | — | — | — | — | — | — | ($5.9m) | $11.2m | ($18.3m) | ($8.2m) | ($1.1m) | |
| Other Non Cash Items | — | — | — | — | — | — | $445k | $1.2m | ($941k) | $18k | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $5k | $3.0m | $22k | $0 | $0 | |
| Purchase Of Intangibles | — | — | — | — | — | — | ($185k) | ($181k) | ($1k) | ($2k) | ($2k) | |
| Purchase Of Investment | — | — | — | — | — | — | ($44.0m) | ($47.6m) | ($26.4m) | ($36.6m) | ($29.5m) | |
| Purchase Of PPE | — | $338k | $173k | $67k | $67k | $97k | ($131k) | ($116k) | ($53k) | ($25k) | ($27k) | |
| Sale Of Investment | — | — | — | — | — | — | $48.3m | $49.3m | $55.8m | $28.1m | $31.9m | |
| Stock Based Compensation | — | — | — | — | — | — | $2.2m | $2.3m | $1.1m | $396k | $280k |